As previously reported, BofA analyst Bryan Spillane upgraded Colgate-Palmolive to Buy from Neutral with a price target of $90, up from $75. The firm raised its FY24 and FY25 estimates as it now factors in 4.5% year-over-year organic sales growth for FY24, up from a prior forecast of 3.6%. The firm expects sales and EPS revision potential to drive share price differentiation among Consumer Staples, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CL:
- Colgate-Palmolive price target raised by $5 at Citi, here’s why
- Unusually active option classes on open November 29th
- Colgate-Palmolive price target raised to $88 from $83 at JPMorgan
- Colgate Palmolive put volume heavy and directionally bearish
- Oracle upgraded, Southwest downgraded: Wall Street’s top analyst calls